Value-Based Kidney Disease Care Can Reduce Hospitalizations & Improve Outcomes

Medicare Advantage members in value-based care (VBC) arrangements for kidney disease management experienced between 3% and 5% fewer unnecessary hospital admissions than their fee-for-service counterparts, according to a Humana analysis of its 2023 Medicare Advantage members. Since 2019 VBC engagement has increased among Humana Medicare Advantage members with chronic kidney disease (CKD), and during this time the company’s medical expense ratio for this group decreased more than 12%.

Additionally, VBC arrangements help lower costs and improve care coordination, helping beneficiaries with CKD manage care proactively and prepare for easier dialysis and transplant conversations with appropriate resources . . .